Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPAR agonists in androgen independent prostate cancer
2006-001398-44Phase 2Terminated
- Sponsor
- Barts Health NHS Trust
- Start
- Mar 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pioglitazone, fenofibrate micronized and calcitriol in prostate cancer (PCa), sponsored by Barts Health NHS Trust. Primary endpoint: PSA doubling time. Started Mar 2006; status: terminated.
02
Drugs
pioglitazonefenofibrate micronizedcalcitriol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2006-001398-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001398-44.